vs

Side-by-side financial comparison of INTELLIGENT BIO SOLUTIONS INC. (INBS) and Sintx Technologies, Inc. (SINT). Click either name above to swap in a different company.

INTELLIGENT BIO SOLUTIONS INC. is the larger business by last-quarter revenue ($896.8K vs $290.0K, roughly 3.1× Sintx Technologies, Inc.). INTELLIGENT BIO SOLUTIONS INC. runs the higher net margin — -298.6% vs -763.8%, a 465.2% gap on every dollar of revenue. On growth, INTELLIGENT BIO SOLUTIONS INC. posted the faster year-over-year revenue change (47.6% vs -46.5%). INTELLIGENT BIO SOLUTIONS INC. produced more free cash flow last quarter ($-1.6M vs $-2.4M). Over the past eight quarters, INTELLIGENT BIO SOLUTIONS INC.'s revenue compounded faster (4.3% CAGR vs -35.0%).

The Institute of Robotics and Intelligent Systems (IRIS) is part of the ETH Zurich, Switzerland. It replaced the existing Institute of Robotics, of the ETH Zurich in October 2002, when Prof. Bradley J. Nelson moved from the University of Minnesota, United States, to ETH Zurich, and succeeded the Prof. Dr. Gerhard Schweitzer.

Sintx Technologies, Inc. is an advanced materials company specializing in R&D and manufacturing of high-performance silicon nitride and other technical ceramic products. It serves key segments including medical implants, aerospace & defense, industrial wear components, and electric vehicle applications, with core markets across North America, Europe and Asia-Pacific.

INBS vs SINT — Head-to-Head

Bigger by revenue
INBS
INBS
3.1× larger
INBS
$896.8K
$290.0K
SINT
Growing faster (revenue YoY)
INBS
INBS
+94.1% gap
INBS
47.6%
-46.5%
SINT
Higher net margin
INBS
INBS
465.2% more per $
INBS
-298.6%
-763.8%
SINT
More free cash flow
INBS
INBS
$750.3K more FCF
INBS
$-1.6M
$-2.4M
SINT
Faster 2-yr revenue CAGR
INBS
INBS
Annualised
INBS
4.3%
-35.0%
SINT

Income Statement — Q2 FY2026 vs Q4 FY2025

Metric
INBS
INBS
SINT
SINT
Revenue
$896.8K
$290.0K
Net Profit
$-2.7M
$-2.2M
Gross Margin
51.3%
64.8%
Operating Margin
-293.9%
-799.3%
Net Margin
-298.6%
-763.8%
Revenue YoY
47.6%
-46.5%
Net Profit YoY
-19.0%
-30.7%
EPS (diluted)
$-2.82
$-0.50

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
INBS
INBS
SINT
SINT
Q4 25
$896.8K
$290.0K
Q3 25
$1.1M
$208.0K
Q2 25
$843.9K
$151.0K
Q1 25
$728.9K
$369.0K
Q4 24
$607.5K
$542.0K
Q3 24
$872.3K
$799.0K
Q2 24
$727.8K
$859.0K
Q1 24
$823.8K
$687.0K
Net Profit
INBS
INBS
SINT
SINT
Q4 25
$-2.7M
$-2.2M
Q3 25
$-3.0M
$-3.5M
Q2 25
$-3.1M
$-2.3M
Q1 25
$-2.5M
$-2.3M
Q4 24
$-2.2M
$-1.7M
Q3 24
$-2.7M
$-6.2M
Q2 24
$-2.8M
$-2.2M
Q1 24
$-3.0M
$-886.0K
Gross Margin
INBS
INBS
SINT
SINT
Q4 25
51.3%
64.8%
Q3 25
46.6%
44.7%
Q2 25
39.8%
37.7%
Q1 25
46.8%
33.3%
Q4 24
36.7%
71.6%
Q3 24
39.8%
73.7%
Q2 24
73.9%
Q1 24
21.7%
67.5%
Operating Margin
INBS
INBS
SINT
SINT
Q4 25
-293.9%
-799.3%
Q3 25
-269.8%
-1613.0%
Q2 25
-367.5%
-1764.9%
Q1 25
-350.3%
-645.8%
Q4 24
-372.8%
-319.6%
Q3 24
-312.4%
-802.0%
Q2 24
-386.3%
-315.5%
Q1 24
-358.6%
-465.4%
Net Margin
INBS
INBS
SINT
SINT
Q4 25
-298.6%
-763.8%
Q3 25
-268.3%
-1701.4%
Q2 25
-366.2%
-1535.1%
Q1 25
-349.0%
-621.1%
Q4 24
-370.3%
-312.7%
Q3 24
-307.9%
-780.9%
Q2 24
-382.5%
-256.6%
Q1 24
-361.5%
-129.0%
EPS (diluted)
INBS
INBS
SINT
SINT
Q4 25
$-2.82
$-0.50
Q3 25
$-0.35
$-3.46
Q2 25
$4.10
$-0.91
Q1 25
$-0.44
$-1.29
Q4 24
$-4.96
$17.04
Q3 24
$-0.70
$-6.96
Q2 24
$9.60
$-3.61
Q1 24
$-1.43
$-21.66

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
INBS
INBS
SINT
SINT
Cash + ST InvestmentsLiquidity on hand
$740.4K
$4.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$11.1M
$2.9M
Total Assets
$17.7M
$9.5M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
INBS
INBS
SINT
SINT
Q4 25
$740.4K
$4.1M
Q3 25
$1.7M
$6.3M
Q2 25
$1.0M
$4.3M
Q1 25
$2.8M
$6.5M
Q4 24
$2.2M
$3.6M
Q3 24
$4.0M
$4.8M
Q2 24
$6.3M
$4.6M
Q1 24
$9.4M
$5.8M
Stockholders' Equity
INBS
INBS
SINT
SINT
Q4 25
$11.1M
$2.9M
Q3 25
$3.6M
$4.1M
Q2 25
$3.0M
$4.0M
Q1 25
$5.1M
$6.1M
Q4 24
$4.4M
$3.9M
Q3 24
$6.1M
$5.6M
Q2 24
$8.3M
$8.8M
Q1 24
$11.1M
$9.9M
Total Assets
INBS
INBS
SINT
SINT
Q4 25
$17.7M
$9.5M
Q3 25
$10.0M
$11.4M
Q2 25
$8.2M
$9.2M
Q1 25
$9.6M
$11.4M
Q4 24
$8.7M
$9.4M
Q3 24
$11.7M
$11.3M
Q2 24
$13.8M
$15.3M
Q1 24
$17.0M
$17.6M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
INBS
INBS
SINT
SINT
Operating Cash FlowLast quarter
$-1.6M
$-2.3M
Free Cash FlowOCF − Capex
$-1.6M
$-2.4M
FCF MarginFCF / Revenue
-182.4%
-822.8%
Capex IntensityCapex / Revenue
7.6%
14.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
INBS
INBS
SINT
SINT
Q4 25
$-1.6M
$-2.3M
Q3 25
$-2.8M
$-2.5M
Q2 25
$-2.2M
$-2.4M
Q1 25
$-2.8M
$-1.3M
Q4 24
$-2.3M
$-1.1M
Q3 24
$-2.4M
$-2.6M
Q2 24
$-2.9M
$-2.2M
Q1 24
$-2.4M
$-2.7M
Free Cash Flow
INBS
INBS
SINT
SINT
Q4 25
$-1.6M
$-2.4M
Q3 25
$-2.9M
$-2.6M
Q2 25
Q1 25
$-1.4M
Q4 24
$-1.3M
Q3 24
$-2.6M
Q2 24
$-2.6M
Q1 24
$-2.9M
FCF Margin
INBS
INBS
SINT
SINT
Q4 25
-182.4%
-822.8%
Q3 25
-262.4%
-1250.5%
Q2 25
Q1 25
-368.6%
Q4 24
-234.3%
Q3 24
-323.0%
Q2 24
-299.7%
Q1 24
-423.1%
Capex Intensity
INBS
INBS
SINT
SINT
Q4 25
7.6%
14.5%
Q3 25
6.3%
40.4%
Q2 25
0.0%
Q1 25
16.0%
Q4 24
26.9%
Q3 24
1.4%
Q2 24
41.8%
Q1 24
25.3%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons